RATIONALE: Existing studies of risk factors for physical impairments in acute lung injury (ALI) survivors were potentially limited by single-center design or relatively small sample size. OBJECTIVES: To evaluate risk factors for three measures of physical impairments commonly experienced by survivors of ALI in the first year after hospitalization. METHODS: A prospective, longitudinal study of 6- and 12-month physical outcomes (muscle strength, 6-minute-walk distance, and Short Form [SF]-36 Physical Function score) for 203 survivors of ALI enrolled from 12 hospitals participating in the ARDS Network randomized trials. Multivariable regression analyses evaluated the independent association of critical illness-related variables and intensive care interventions with impairments in each physical outcome measure, after adjusting for patient demographics, comorbidities, and baseline functional status. MEASUREMENTS AND MAIN RESULTS: At 6 and 12 months, respectively, mean (± SD) values for strength (presented as proportion of maximum strength score evaluated using manual muscle testing) was 92% (± 8%) and 93% (± 9%), 6-minute-walk distance (as percent-predicted) was 64% (± 22%) and 67% (± 26%), and SF-36 Physical Function score (as percent-predicted) was 61% (± 36%) and 67% (± 37%). After accounting for patient baseline status, there was significant association and statistical interaction of mean daily dose of corticosteroids and intensive care unit length of stay with impairments in physical outcomes. CONCLUSIONS: Patients had substantial impairments, from predicted values, for 6-minute-walk distance and SF-36 Physical Function outcome measures. Minimizing corticosteroid dose and implementing existing evidence-based methods to reduce duration of intensive care unit stay and associated patient immobilization may be important interventions for improving ALI survivors' physical outcomes.
RCT Entities:
RATIONALE: Existing studies of risk factors for physical impairments in acute lung injury (ALI) survivors were potentially limited by single-center design or relatively small sample size. OBJECTIVES: To evaluate risk factors for three measures of physical impairments commonly experienced by survivors of ALI in the first year after hospitalization. METHODS: A prospective, longitudinal study of 6- and 12-month physical outcomes (muscle strength, 6-minute-walk distance, and Short Form [SF]-36 Physical Function score) for 203 survivors of ALI enrolled from 12 hospitals participating in the ARDS Network randomized trials. Multivariable regression analyses evaluated the independent association of critical illness-related variables and intensive care interventions with impairments in each physical outcome measure, after adjusting for patient demographics, comorbidities, and baseline functional status. MEASUREMENTS AND MAIN RESULTS: At 6 and 12 months, respectively, mean (± SD) values for strength (presented as proportion of maximum strength score evaluated using manual muscle testing) was 92% (± 8%) and 93% (± 9%), 6-minute-walk distance (as percent-predicted) was 64% (± 22%) and 67% (± 26%), and SF-36 Physical Function score (as percent-predicted) was 61% (± 36%) and 67% (± 37%). After accounting for patient baseline status, there was significant association and statistical interaction of mean daily dose of corticosteroids and intensive care unit length of stay with impairments in physical outcomes. CONCLUSIONS:Patients had substantial impairments, from predicted values, for 6-minute-walk distance and SF-36 Physical Function outcome measures. Minimizing corticosteroid dose and implementing existing evidence-based methods to reduce duration of intensive care unit stay and associated patient immobilization may be important interventions for improving ALI survivors' physical outcomes.
Authors: M H Kollef; S D Shapiro; P Silver; R E St John; D Prentice; S Sauer; T S Ahrens; W Shannon; D Baker-Clinkscale Journal: Crit Care Med Date: 1997-04 Impact factor: 7.598
Authors: Mace Coday; Carla Boutin-Foster; Tamara Goldman Sher; Jennifer Tennant; Mary L Greaney; Sandra D Saunders; Grant W Somes Journal: Ann Behav Med Date: 2005-04
Authors: Donald F Slack; Douglas S Corwin; Nirav G Shah; Carl B Shanholtz; Avelino C Verceles; Giora Netzer; Kevin M Jones; Clayton H Brown; Michael L Terrin; Jeffrey D Hasday Journal: Crit Care Med Date: 2017-07 Impact factor: 7.598
Authors: Carla M Sevin; Sarah L Bloom; James C Jackson; Li Wang; E Wesley Ely; Joanna L Stollings Journal: J Crit Care Date: 2018-08 Impact factor: 3.425
Authors: Biren B Kamdar; Minxuan Huang; Victor D Dinglas; Elizabeth Colantuoni; Till M von Wachter; Ramona O Hopkins; Dale M Needham Journal: Am J Respir Crit Care Med Date: 2017-10-15 Impact factor: 21.405
Authors: Shan L Ward; Autumn Turpin; Aaron C Spicer; Marsha J Treadwell; Gwynne D Church; Heidi R Flori Journal: Pediatr Crit Care Med Date: 2017-01 Impact factor: 3.624
Authors: Victor D Dinglas; Ann M Parker; Dereddi Raja S Reddy; Elizabeth Colantuoni; Jennifer M Zanni; Alison E Turnbull; Archana Nelliot; Nancy Ciesla; Dale M Needham Journal: Ann Am Thorac Soc Date: 2014-10
Authors: Michael E Detsky; Michael O Harhay; Dominique F Bayard; Aaron M Delman; Anna E Buehler; Saida A Kent; Isabella V Ciuffetelli; Elizabeth Cooney; Nicole B Gabler; Sarah J Ratcliffe; Mark E Mikkelsen; Scott D Halpern Journal: Ann Am Thorac Soc Date: 2017-10
Authors: Kitty S Chan; Marina Mourtzakis; Lisa Aronson Friedman; Victor D Dinglas; Catherine L Hough; E Wesley Ely; Peter E Morris; Ramona O Hopkins; Dale M Needham Journal: Crit Care Med Date: 2018-08 Impact factor: 7.598